Evaxion Biotech A/S Quarterly Research And Development Expense in USD from Q1 2020 to Q2 2023

Taxonomy & unit
ifrs-full: USD
Summary
Evaxion Biotech A/S annual/quarterly Research And Development Expense history and growth rate from Q1 2020 to Q2 2023.
  • Evaxion Biotech A/S Research And Development Expense for the quarter ending June 30, 2023 was $2.94M, a 28.6% decline year-over-year.
  • Evaxion Biotech A/S annual Research And Development Expense for 2023 was $11.9M, a 30.1% decline from 2022.
  • Evaxion Biotech A/S annual Research And Development Expense for 2022 was $17.1M, a 12.9% decline from 2021.
  • Evaxion Biotech A/S annual Research And Development Expense for 2021 was $19.6M, a 79.6% increase from 2020.
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $2.94M -$1.18M -28.6% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-17
Q2 2022 $19.5M $4.11M -$999K -19.5% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-17
Q1 2022 $20.5M $4.8M +$911K +23.4% Jan 1, 2022 Mar 31, 2022 6-K 2022-05-12
Q4 2021 $19.6M $6.16M +$3.31M +116% Oct 1, 2021 Dec 31, 2021 20-F 2024-03-26
Q3 2021 $16.3M $4.42M +$1.45M +48.9% Jul 1, 2021 Sep 30, 2021 6-K 2021-11-10
Q2 2021 $14.8M $5.11M +$2.54M +98.9% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-11
Q1 2021 $12.3M $3.89M +$1.38M +55.1% Jan 1, 2021 Mar 31, 2021 6-K 2022-05-12
Q4 2020 $10.9M $2.86M Oct 1, 2020 Dec 31, 2020 20-F 2023-04-28
Q3 2020 $2.97M Jul 1, 2020 Sep 30, 2020 6-K 2021-11-10
Q2 2020 $2.57M Apr 1, 2020 Jun 30, 2020 6-K 2021-08-13
Q1 2020 $2.51M Jan 1, 2020 Mar 31, 2020 6-K 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.